Publications by authors named "Heike Hintelmann"

Claim this Profile
C
CAR T cells as micropharmacies against solid cancers: Combining effector T-cell mediated cell death with vascular targeting in a one-step engineering process.
Bianca Altvater, Sareetha Kailayangiri, Christian Spurny, Maike Flügge, Jutta Meltzer, Heike Hintelmann

Cancer Gene Ther· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting Tissue Factor to Tumor Vasculature to Induce Tumor Infarction.
Andrew F Berdel, Christian Schwöppe, Caroline Brand, Saliha Harrach, Kathrin Brömmel, Heike Hintelmann

Cancers (Basel)· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Animal Safety, Toxicology, and Pharmacokinetic Studies According to the ICH S9 Guideline for a Novel Fusion Protein tTF-NGR Targeting Procoagulatory Activity into Tumor Vasculature: Are Results Predictive for Humans?
Wolfgang E Berdel, Saliha Harrach, Caroline Brand, Kathrin Brömmel, Andrew F Berdel, Heike Hintelmann

Cancers (Basel)· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiation synergizes with antitumor activity of CD13-targeted tissue factor in a HT1080 xenograft model of human soft tissue sarcoma.
Caroline Brand, Burkhard Greve, Tobias Bölling, Hans T Eich, Normann Willich, Heike Hintelmann

PLoS One· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combinatorial effects of doxorubicin and retargeted tissue factor by intratumoral entrapment of doxorubicin and proapoptotic increase of tumor vascular infarction.
Janine Stucke-Ring, Julian Ronnacker, Caroline Brand, Carsten Höltke, Christoph Schliemann, Heike Hintelmann

Oncotarget· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NG2 proteoglycan as a pericyte target for anticancer therapy by tumor vessel infarction with retargeted tissue factor.
Caroline Brand, Christoph Schliemann, Janine Ring, Torsten Kessler, Sebastian Bäumer, Heike Hintelmann

Oncotarget· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-Energy Ultrasound Treatment Improves Regional Tumor Vessel Infarction by Retargeted Tissue Factor.
Caroline Brand, Stefanie Dencks, Georg Schmitz, Mareike Mühlmeister, Jörg Stypmann, Heike Hintelmann

J Ultrasound Med· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vascular infarction by subcutaneous application of tissue factor targeted to tumor vessels with NGR-peptides: activity and toxicity profile.
Johannes Dreischalück, Christian Schwöppe, Tilmann Spieker, Torsten Kessler, Klaus Tiemann, Heike Hintelmann

Int J Oncol· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tissue-factor fusion proteins induce occlusion of tumor vessels.
Christian Schwöppe, Torsten Kessler, Thorsten Persigehl, Ruediger Liersch, Heike Hintelmann

Thromb Res· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of VEGF-C and its receptor VEGFR-3 in the bone marrow of patients with acute myeloid leukaemia.
Ruediger Liersch, Christoph Schliemann, Ralf Bieker, Heike Hintelmann, Thomas Buechner

Leuk Res· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generation of fusion proteins for selective occlusion of tumor vessels.
Torsten Kessler, Christian Schwöppe, Ruediger Liersch, Christoph Schliemann, Heike Hintelmann

Curr Drug Discov Technol· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of vessel architecture and vascular stability in non-small cell lung cancer.
Niels Reinmuth, Elisabeth Piegelbrock, Miriam Raedel, Nicole Fehrmann, Heike Hintelmann

Lung Cancer· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of angiopoietins and their receptor Tie2 in the bone marrow of patients with acute myeloid leukemia.
Christoph Schliemann, Ralf Bieker, Teresa Padro, Torsten Kessler, Heike Hintelmann

Haematologica· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The catalytic domain of endogenous urokinase-type plasminogen activator is required for the mitogenic activity of platelet-derived and basic fibroblast growth factors in human vascular smooth muscle cells.
Teresa Padró, Rolf M Mesters, Berno Dankbar, Heike Hintelmann, Ralf Bieker

J Cell Sci· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis